Search

Dr. David Harper, an expert in phage technology, is launching The Phage Adviser, an advisory service for companies and researchers, aiming to provide guidance and support in the emerging field of phage technology.

Mike Tisza published a new pre-print (& great Twitter thread) on how bacterial and phage communities interact in the gut during the first years of life, as found by exploring the TEDDY dataset (12k samples from 800+ children in 4 countries)

Larissa Krüger (University of St. Andrews, UK) and colleagues discovered a reversible conjugation mechanism that regulates immune response to phage infection in Bacillus cereus bacteria.

Barbara Maciejewska (University of Wrocław, Poland) and colleagues elucidated the structure and function of the capsular depolymerase KP34gp57 from Klebsiella phage KP34, describing for the first time monomeric phage depolymerases (’mini-de

Sicelo Dlamini (University of Mpumalanga, South Africa) and colleagues studied how different encapsulation techniques affect phage viability and stability under simulated gastric conditions, and found that alginate–carrageenan-CaCO3 encapsu

Frank Oechslin (Université Laval, Canada) and colleagues have discovered that dairy practices have selected for thermostable endolysins in streptococcal phages.

Medical-grade phage is now available for expanded access through Tolka.ai's waitlist, after a year of hard work by Johan Wikstrom, Keqing Li, Thomas Hunt, Volodymyr Kulchytskyi, and the broader phage community; phage researchers can learn m

BBC Radio 4, a popular radio station in the United Kingdom, published a podcast episode titled "Bacteria: The Tiny Giants, Forests, Pharma and Phages" that explores various aspects of phage research and their impact on ecosystems.

From @scientiff via Twitter: Hey #scitwitter! I’m troubleshooting some #phage DNA extraction woes with our undergrads. We use phenol-chloroform-isoamyl and phase-lock gels for the process but we’re still getting high 260/230 after elution.

The first patient in Armata Pharmaceuticals’ newest trial has been treated. This is part of the Phase 2a portion of their diSArm study, which evaluates the potential treatment of S. aureus bacteremia.

Jason Wilson (University of Sheffield) and colleagues published a new preprint on the molecular mechanism of phage tail contraction, shedding light on the structure of an S-layer-penetrating phage.

In a new Current Opinion in Microbiology piece, Jochen Klumpp, Matthew Dunne, and Martin Loessner explore the potential of phage receptor-binding proteins for diagnostic and therapeutic applications.

Juergen Eckhardt, writing for Forbes magazine, recently wrote an article on phage therapy.

Min Wang (Ocean University of China) and colleagues have identified a new Halomonas phage in the Mariana Trench. This is the deepest known phage isolation.

Phage Bites is back! The Bacteriophage Biology & Therapeutics (BBT) SIG is hosting their second symposium Sept 26 featuring brief presentations from postgraduate students on phage-related topics, followed by an expert panel discussion on "S

The 4th International Conference on Bacteriophage Research and Antimicrobial Resistance is hosting ”Phages for Life”, a hybrid conference from Sept 28-30 in Chennai, India and online, with the theme of “Harnessing bacteriophages for human w

Phage Futures 2023, a free, one-day online conference which aims to bring together phage researchers and industry professionals to explore phage commercialization, is being hosted online October 25th by Kisaco Research. Read the full Agenda

Australia’s The Project showcases new Phage Australia work on a new children's CF clinical trial using phages.

Parallel Health, a new US phage skincare company, has announced $2.3M in funding and launched a custom phage therapy skin serum that targets bacteria causing skin conditions, offering personalized treatments based on individual skin microbi

Contrafect, a company developing ‘direct lytic agents’ (which include lysins and amurin peptides), has submitted an IND application for preliminary approval of a new IV antibacterial agent for treatment of hospital-acquired and ventilator-a